By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

TissueGene, Inc. 

209 Perry Parkway, Suite 13

Gaithersburg  Maryland  20877  U.S.A.
Phone: 301-921-6000 Fax: 301-921-6011


SEARCH JOBS


Industry
Biotechnology






Company News
TissueGene, Inc. Announces FDA Acceptance Of Invossa As Proprietary Name For TissueGene-C 6/24/2015 8:51:53 AM
TissueGene, Inc. Announces Presentation And Webcast At The Jefferies and Co. 2015 Healthcare Conference 5/28/2015 7:57:29 AM
TissueGene, Inc. Announces Special Protocol Assessment (SPA) Agreement With The FDA For Its Phase 3 Clinical Trial Of Invossa For Patients Suffering From Osteoarthritis Of The Knee 5/18/2015 6:27:34 AM
TissueGene, Inc. Presents Phase 2 Data For Its Novel Cell Therapy For The Treatment Of Osteoarthritis Of The Knee 5/11/2015 7:26:18 AM
TissueGene, Inc. Hires Robert Newman As Chief Operating Officer 4/21/2015 11:15:43 AM
TissueGene, Inc. Receives Recommendations From FDA On Pathway To Phase 3 Trial Of TG-C For Treatment Of Osteoarthritis Of The Knee 11/17/2014 10:24:32 AM
TissueGene, Inc. Completes Enrollment in U.S. Phase II Study of TG-C in Patients With Knee Osteoarthritis 11/14/2012 8:33:28 AM
TissueGene, Inc. Initiates Patient Enrollment for a Phase II Study of TG-C for Osteoarthritis of the Knee 5/19/2011 10:02:11 AM
PharmaVigilant Supports TissueGene, Inc.'s Phase II Trial With Groundbreaking Imaging Capabilities 2/2/2010 11:44:05 AM
TissueGene, Inc. Announces Regulatory Allowance to Initiate Phase IIa Study of TG-C in South Korea for Osteoarthritis of the Knee 3/2/2009 10:24:48 AM
12
//-->